Advantages of FIT As CRC Screening Method Discussed

Share this content:
Advantages of FIT As CRC Screening Method Discussed
Advantages of FIT As CRC Screening Method Discussed

TUESDAY, Oct. 25, 2016 (HealthDay News) -- Fecal immunochemical testing (FIT) has advantages as a colorectal cancer (CRC) screening method, and should be a component of a screening program, according to an Ideas and Opinions piece published online Oct. 25 in the Annals of Internal Medicine.

In light of recent findings questioning the effectiveness of colonoscopy, David S. Weinberg, M.D., from the Fox Chase Cancer Center in Philadelphia, and colleagues discussed CRC screening methods.

The researchers note that a U.S. Multi-Society Task Force recently released an examination of the evidence relating to use of FIT for CRC screening, emphasizing the advantages of FIT over guaiac-based fecal occult blood testing. Advantages include higher sensitivity while maintaining similar specificity; more consistent detection of advanced adenomas; and patient preference for FIT. Recent studies show that FIT-based screening yields a reduction in CRC incidence similar to that of colonoscopy when adherence to serial completion is high, and patients are more likely to choose FIT over colonoscopy; consequently, more cancers (but fewer advanced adenomas) could be detected with FIT screening. Practical concerns surround implementation of annual FIT screening; for example, a large-scale FIT screening would require efficient tracking mechanisms.

"For primary care and other clinicians who provide CRC screening services, this authoritative consensus statement offers strong evidence for FIT as an excellent alternative for CRC prevention," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Illicit Marijuana Use Up in States With Legal Medical Use

Illicit Marijuana Use Up in States With Legal ...

Cannabis use disorder is also rising faster in states with legalization laws

Chromosome Instability Test Prognostic in NSCLC

Chromosome Instability Test Prognostic in NSCLC

Chromosome instability associated with higher risk of relapse, death within 2 years

CDC: Opioid-Related Mortality Rate Might Be Underestimated

CDC: Opioid-Related Mortality Rate Might Be Underestimated

Death certificates from drug-linked infections may not label opioids as possible cause

is free, fast, and customized just for you!

Already a member?

Sign In Now »